RecruitingNCT05571774

Construction of a Database for TTP

Construction of a Database for Thrombotic Thrombocytopenic Purpura

Sponsor

The First Affiliated Hospital of Soochow University

Enrollment

500 participants

Start Date

Oct 20, 2022

Study Type

OBSERVATIONAL

Conditions

TTP - Thrombotic Thrombocytopenic Purpura

Summary

Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Oct 20, 2022, to Oct 20, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical related data of thrombotic thrombocytopenic purpura.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study is building a database of patients with Thrombotic Thrombocytopenic Purpura (TTP) — a rare and serious blood disorder where tiny clots form throughout small blood vessels, causing low platelet counts, anemia, and potentially brain and organ damage. It is caused by a severe deficiency of an enzyme called ADAMTS13. The database will help researchers better understand the disease and develop improved treatments. You may be eligible if: - You have severe ADAMTS13 deficiency (activity below 10%), documented in your medical history or at screening You may NOT be eligible if: - The investigator determines you are unable or unwilling to cooperate with study procedures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.